Spectrum: Autism Research News

Measuring the outcome of clinical trials
Featured Articles

Why don’t we have better drugs for autism?
Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.

Questions for Gahan Pandina: New tool may aid autism trials
A new ‘knowledge engine’ collects reams of behavioral and sensory data to create highly sensitive outcome measures for autism drugs.

Despite setbacks, fragile X drugs file into clinical trials
Our infographic displays efforts to develop treatments for fragile X syndrome. So far, none of them have passed muster in clinical trials.
From The Archives
TAGS:
autism
By joining the discussion, you agree to our privacy policy.